Selected research
Industry Research
Amifostine Hydrate Industry Research Report 2026
Market perspective
The global Amifostine Hydrate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amifostine Hydrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amifostine Hydrate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amifostine Hydrate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amifostine Hydrate include Sun Pharmaceutical, Luye Pharma, Taj Pharmaceuticals, Mingren Pharma, Merro Pharmaceutical and Clinigen Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amifostine Hydrate market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amifostine Hydrate Market by Company
Sun Pharmaceutical
Luye Pharma
Taj Pharmaceuticals
Mingren Pharma
Merro Pharmaceutical
Clinigen Group
Amifostine Hydrate Segment by Type
400mg/Dose
500mg/Dose
Amifostine Hydrate Segment by Application
Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others
Amifostine Hydrate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amifostine Hydrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amifostine Hydrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amifostine Hydrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amifostine Hydrate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amifostine Hydrate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amifostine Hydrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 400mg/Dose
- 500mg/Dose
Applications
- Ovarian Cancer Adjuvant Therapy
- Head and Neck Cancer Adjuvant Therapy
- Others
Companies covered
- Sun Pharmaceutical
- Luye Pharma
- Taj Pharmaceuticals
- Mingren Pharma
- Merro Pharmaceutical
- Clinigen Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amifostine Hydrate Market Size (2021-2032)
- 2.2.2 Global Amifostine Hydrate Sales (2021-2032)
- 2.2.3 Global Amifostine Hydrate Market Average Price (2021-2032)
- 2.3 Amifostine Hydrate by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 400mg/Dose
- 2.3.3 500mg/Dose
- 2.4 Amifostine Hydrate by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ovarian Cancer Adjuvant Therapy
- 2.4.3 Head and Neck Cancer Adjuvant Therapy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amifostine Hydrate Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amifostine Hydrate Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Amifostine Hydrate Revenue of Manufacturers (2021-2026)
- 3.4 Global Amifostine Hydrate Average Price by Manufacturers (2021-2026)
- 3.5 Global Amifostine Hydrate Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amifostine Hydrate, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amifostine Hydrate, Product Type & Application
- 3.8 Global Manufacturers of Amifostine Hydrate, Established Date
- 3.9 Global Amifostine Hydrate Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical
- 4.1.1 Sun Pharmaceutical Company Information
- 4.1.2 Sun Pharmaceutical Business Overview
- 4.1.3 Sun Pharmaceutical Amifostine Hydrate Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Amifostine Hydrate Product Portfolio
- 4.1.5 Sun Pharmaceutical Recent Developments
- 4.2 Luye Pharma
- 4.2.1 Luye Pharma Company Information
- 4.2.2 Luye Pharma Business Overview
- 4.2.3 Luye Pharma Amifostine Hydrate Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Luye Pharma Amifostine Hydrate Product Portfolio
- 4.2.5 Luye Pharma Recent Developments
- 4.3 Taj Pharmaceuticals
- 4.3.1 Taj Pharmaceuticals Company Information
- 4.3.2 Taj Pharmaceuticals Business Overview
- 4.3.3 Taj Pharmaceuticals Amifostine Hydrate Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Taj Pharmaceuticals Amifostine Hydrate Product Portfolio
- 4.3.5 Taj Pharmaceuticals Recent Developments
- 4.4 Mingren Pharma
- 4.4.1 Mingren Pharma Company Information
- 4.4.2 Mingren Pharma Business Overview
- 4.4.3 Mingren Pharma Amifostine Hydrate Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mingren Pharma Amifostine Hydrate Product Portfolio
- 4.4.5 Mingren Pharma Recent Developments
- 4.5 Merro Pharmaceutical
- 4.5.1 Merro Pharmaceutical Company Information
- 4.5.2 Merro Pharmaceutical Business Overview
- 4.5.3 Merro Pharmaceutical Amifostine Hydrate Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merro Pharmaceutical Amifostine Hydrate Product Portfolio
- 4.5.5 Merro Pharmaceutical Recent Developments
- 4.6 Clinigen Group
- 4.6.1 Clinigen Group Company Information
- 4.6.2 Clinigen Group Business Overview
- 4.6.3 Clinigen Group Amifostine Hydrate Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Clinigen Group Amifostine Hydrate Product Portfolio
- 4.6.5 Clinigen Group Recent Developments
5 Global Amifostine Hydrate Market Scenario by Region
- 5.1 Global Amifostine Hydrate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amifostine Hydrate Sales by Region: 2021-2032
- 5.2.1 Global Amifostine Hydrate Sales by Region: 2021-2026
- 5.2.2 Global Amifostine Hydrate Sales by Region: 2027-2032
- 5.3 Global Amifostine Hydrate Revenue by Region: 2021-2032
- 5.3.1 Global Amifostine Hydrate Revenue by Region: 2021-2026
- 5.3.2 Global Amifostine Hydrate Revenue by Region: 2027-2032
- 5.4 North America Amifostine Hydrate Market Facts & Figures by Country
- 5.4.1 North America Amifostine Hydrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amifostine Hydrate Sales by Country (2021-2032)
- 5.4.3 North America Amifostine Hydrate Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Amifostine Hydrate Market Facts & Figures by Country
- 5.5.1 Europe Amifostine Hydrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amifostine Hydrate Sales by Country (2021-2032)
- 5.5.3 Europe Amifostine Hydrate Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Amifostine Hydrate Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amifostine Hydrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amifostine Hydrate Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amifostine Hydrate Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amifostine Hydrate Market Facts & Figures by Country
- 5.7.1 South America Amifostine Hydrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amifostine Hydrate Sales by Country (2021-2032)
- 5.7.3 South America Amifostine Hydrate Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Amifostine Hydrate Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amifostine Hydrate Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amifostine Hydrate Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amifostine Hydrate Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Amifostine Hydrate Sales by Type (2021-2032)
- 6.1.1 Global Amifostine Hydrate Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Amifostine Hydrate Sales Market Share by Type (2021-2032)
- 6.2 Global Amifostine Hydrate Revenue by Type (2021-2032)
- 6.2.1 Global Amifostine Hydrate Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amifostine Hydrate Revenue Market Share by Type (2021-2032)
- 6.3 Global Amifostine Hydrate Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amifostine Hydrate Sales by Application (2021-2032)
- 7.1.1 Global Amifostine Hydrate Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Amifostine Hydrate Sales Market Share by Application (2021-2032)
- 7.2 Global Amifostine Hydrate Revenue by Application (2021-2032)
- 7.2.1 Global Amifostine Hydrate Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amifostine Hydrate Revenue Market Share by Application (2021-2032)
- 7.3 Global Amifostine Hydrate Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amifostine Hydrate Value Chain Analysis
- 8.1.1 Amifostine Hydrate Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amifostine Hydrate Production Mode & Process
- 8.2 Amifostine Hydrate Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amifostine Hydrate Distributors
- 8.2.3 Amifostine Hydrate Customers
9 Global Amifostine Hydrate Analyzing Market Dynamics
- 9.1 Amifostine Hydrate Industry Trends
- 9.2 Amifostine Hydrate Industry Drivers
- 9.3 Amifostine Hydrate Industry Opportunities and Challenges
- 9.4 Amifostine Hydrate Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst